Guangdong Hybribio Biotech Co Ltd Financial Flexibility Index
Guangdong Hybribio Biotech Co Ltd financial flexibility index. Guangdong Hybribio Biotech Co Ltd (300639) has a Financial Flexibility Index of 0.15x as of September 2025. Free cash flow of CN¥82.74 Million (operating CF CN¥66.39 Million minus capex CN¥16.36 Million) represents 0% of total liabilities (CN¥553.76 Million). See how much free cash does Guangdong Hybribio Biotech Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Guangdong Hybribio Biotech Co Ltd (2012–2025)
Financial flexibility index of Guangdong Hybribio Biotech Co Ltd from 2012 to 2025. Historical Financial Flexibility Index trend for Guangdong Hybribio Biotech Co Ltd across 14 annual periods. Check 300639 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Guangdong Hybribio Biotech Co Ltd Financial Flexibility Index by Year (2012–2025)
Guangdong Hybribio Biotech Co Ltd financial flexibility index by year from 2012 to 2025. Year-by-year free cash flow to debt coverage for Guangdong Hybribio Biotech Co Ltd. For the full cash flow conversion analysis, see Guangdong Hybribio Biotech Co Ltd (300639) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.89x | CN¥434.00 Million | CN¥341.61 Million | CN¥485.86 Million | ▲ +126.7% |
| 2024 | 0.39x | CN¥227.11 Million | CN¥78.78 Million | CN¥576.44 Million | ▼ -65.0% |
| 2023 | 1.12x | CN¥704.92 Million | CN¥319.60 Million | CN¥627.05 Million | ▼ -17.3% |
| 2022 | 1.36x | CN¥2.04 Billion | CN¥1.31 Billion | CN¥1.50 Billion | ▼ -19.2% |
| 2021 | 1.68x | CN¥1.27 Billion | CN¥631.34 Million | CN¥756.37 Million | ▼ -9.3% |
| 2020 | 1.85x | CN¥598.42 Million | CN¥311.30 Million | CN¥322.69 Million | ▼ -32.7% |
| 2019 | 2.75x | CN¥309.39 Million | CN¥112.83 Million | CN¥112.33 Million | ▲ +32.5% |
| 2018 | 2.08x | CN¥224.82 Million | CN¥80.39 Million | CN¥108.17 Million | ▲ +40.4% |
| 2017 | 1.48x | CN¥146.16 Million | CN¥79.17 Million | CN¥98.74 Million | ▼ -18.6% |
| 2016 | 1.82x | CN¥140.92 Million | CN¥63.63 Million | CN¥77.49 Million | ▼ -18.3% |
| 2015 | 2.23x | CN¥178.36 Million | CN¥48.47 Million | CN¥80.11 Million | ▼ -20.1% |
| 2014 | 2.79x | CN¥114.37 Million | CN¥34.65 Million | CN¥41.06 Million | ▲ +347.5% |
| 2013 | 0.62x | CN¥49.57 Million | CN¥22.89 Million | CN¥79.64 Million | ▼ -47.1% |
| 2012 | 1.18x | CN¥45.83 Million | CN¥16.08 Million | CN¥38.96 Million | — |